Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
mitoquinone (2 trials)
ubiquinone (1 trial)
Fatty Liver (Phase 2)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis C (Phase 2)
Hepatitis C, Chronic (Phase 2)
Liver Diseases (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Parkinson Disease (Phase 2)
Trials (3 total)
Trial APIs (2 total)